You are here

Michael Goettler

Global President, Rare Disease Global Innovative Pharma Business

“Helping patients with rare diseases is a mission of global proportions. We are prepared for that challenge. Pfizer is in a unique position to provide medicines that span geographies, transcend patient diversity, and offer meaningful solutions to distinct patient populations struggling with rare diseases. The global medical community—and the pharmaceutical sector in particular—has a responsibility to devise better treatments for patients with rare diseases. It’s a privilege for us to assume a leadership role in that shared mission. At the heart of this work is our concern and compassion for patients and families whose lives are affected by rare disease. They are our true inspiration.”